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Infancy is probably the most nutritionally demanding period of Hfe. Weight
typically doubles during the first 4 to 6 months and triples by the end of the first year (1).
At this rate of growth, adequate nutrient intake is a must. Infants generally get their diet
solely from one food source which may be human milk, commercial infant formulas, or
both.
The importance of trace elements has been recognized for a few decades. They
have very important functions in growth and development. During infancy especially, it is
very important to ensure that appropriate levels of utilizable essential trace elements are
pmvided. Elements that fall under this trace element specification are: magnesium, iron,
zinc, copper, iodine, selenium, chromium, manganese, molybdenum and fluorine. Most
of the requirement for each element is measured as micrograms (Ilg) instead of milligrams
(mg) or grams (g).
The Problem
Breast milk is considered to be the ideal food for infants. It provides a complete
nutrient profile as wen as immune system components for the first few months of the
infant's life (1). But the popularity of bottle feeding newborn infants has increased
dramatically in the last 50 years, mostly in developing countries, but in the United States as
well.
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Few data are available concerning the amount or the bioavailability, of some trace
elements contained in infant formulas. Does infant formula provide insufficient or
excessive amounst of these elements? We do know that infant formula does not provide
th.e immunity protection that human colostrum does.
Infant formulas are relatively expensive. Its use in developing countries can be a
some disadvantage to infants, not only physically tbut also economically to the parents of
the infants. Some nonnal healthy mothers actually prefer to bottle feed their infants with
infant formula instead of their natural milk because they think that infant formula is much
better in quality compared to breast milk. It is very important to give the society complete
information about the advantages and disadvantages of infant formula, and providing
complete data concerning the trace elements is one step (3).
Purpose of the Study
The purpose of this research was to estimate the content of copper, zinc, selenium
and manganese, in several kinds of infant formulas manufactured by Ross Laboratories
(Columbus, Ohio), to contribute to a data bank to establish ranges of these trace elements
and to detennine whether the infant formulas provide them within the ranges normally
found in human milk.
Objectives of the Study
This study was designed to investigate the following objectives:
I . Determine selenium, manganese, zinc, and copper concentration in selected
infant formulas.
2. Accumulate data in order to help establish ranges of selenium and
manganese in infant formula.
3. Compare the value of copper and zinc content in infant formulas in the study
with the value reported by the manufacturer.
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4. Compare the data with the copper, zinc, selenium and manganese
concentration of milk from a nonnal healthy mother in her child bearing age.
5. Compare the data with the copper, zinc, selenium, and manganese
recommendations for infants.
The design of this study was based on the fonowing assumptions:
1. The concentrations of selenium, manganese, zinc and copper in infant
formula will be higher compared to that in breast milk of a normal, healthy
mother of child bearing age.
2. The infant formula content of selenium and manganese, zinc and copper
are within the range established in the Estimated Safe and Adequate Daily
Dietary Intake (ESADDD or Recommended Dietary Allowance (RDA).
Scope and Limitation
Some limitations that may be present in this research :
1 . Human error of inaccuracy during
a. weighing the samples.
b. measuring the volume of the samples.
c. adding nitric acid and hydrogen peroxide to the samples.
2. Possible contamination during
a. cleaning and preparing the tubes for the sample.
b. adding nitric acid and peroxide to the sample.
c. diluting the sample.




Modified and commercially manufactured infant formulas prepared from cow's
milk, soy bean, and various cereals are widely available and used for infant feeding. Four
major companies that supply this large demand for infant formula are Wyeth, Mead
Johnson, Carnation, and Ross Laboratories.
Due to some concern about the composition of infant fonnulas, the Committee on
Nutrition of the American Academy of Pediatrics issued a policy statement to standardize
these products (2). The standard of comparison uses breast milk composition from healthy
mothers as its base (Table I).
Some of the] 8 trace minerals have been shown to have major roles in nonnal
human body function, and they are magnesium, iron, zinc, copper, iodine, selenium,
chromium, manganese, molybdenum and fluorine. Data are available for only magnesium,
iron, zinc, copper, and iodine in the commercially available cow's milk and soy milk based
formula manufactured by Ross Laboratories (1).
This study examines four trace minerals (selenium, manganese, zinc and copper) in
several kinds of infant fonnulas manufactured by Ross Laboratories. The formulas are
SIM~AC® with Iron infant formula (ready to feed, concentrated, and powder form),
SIMlLAC® PM 60/40 Low Iron infant formula (ready to feed and powder form),
ALIMENTIJM® Protein Hydrolysate infant fonnula with iron (ready to feed form),
SIMlLAC® Low Iron infant formula (ready to feed. concentrated, and powder form).
ISOMIL® Soy Fonnula with Iron (ready to feed, concentrated. and powder form), and
SIMILAC® Special Care infant formula with iron
(ready to use form). The result will be compared to the composition of milk from a healthy
mother.
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a From Committee on Nutrition of the AAP 1985 (2).
b Standard Deviation.
c From Styslinger L, Kirksey A: American Journal of Clinical Nutrition 41 :21,1985.
d From Brown CM: Journal of Pediatric of Gastrocnterol Nutrition 5:278,1986.
e From Sandberg DP, James AB, Charles AH: American Journal of Clinical
Nutrition 34: 1717, 1981.




The History of Infant Fonnula
According to Hunter (3), the major drive for infant fonnulas started in the mid
1800's, when there was a decline of wet nursing. The first company that manufactured
evaporated milk was Borden Company in 1856. When the sterilization process was
discovered in 1883, infant formulas were developed. This sterilization process modifies
the casein curds and make it digestible by the infant's digestive track.
By 1930, infant fonnulas had become a giant and profitable enterprise that was
aggressively promoted (3). During World War II when the number of women employed
away from home increased, bottle feeding became a norm in United States and Western
Europe.
Evaporated milk was the most widely used ingredient for infant fonnulas until
1950. By 1960,80 % of all bottle-fed babies used evaporated milk. But after 1960, most
evaporated milk was not used anymore and instead, it was replaced by commercial infant
formulas (3). Today, there are hundreds of infant formula brands world wide. In United
States, these companies dominate the market: Wyeth, Mead Johnson, Carnation, Ross
Laboratory are among them.
Most infant formulas are based on cow's milk. Some of them use a protein base of
soybean isolate for infants allergic to protein in cow's milk or for infants not able to digest
it. For infants with an inborn error of metabolism, there are special formulas on the
market
Several problems arise from improper infant fonnula preparation, especially those
which are not ready to use and need to be prepared. Feeding the infant with improperly
prepared fonnulacontaining high sodium concentration creates an abnonnal thirst. The
infant will cry for more formula which, again, makes the infant more thirsty.
This excess sodium problem leads to overweight infants and has caused manufacturers to
changed the composition of infant fonnula. A reduced amount of sodium became
mandatory in 1974.
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Differences Between Cow's Milk and Human Breast Milk and Some Problems Caused by
Infant Fonnula
All mamals' milk are not only highly complex, but also very spedes specific.
Cow's milk specificaiUy matches needs for calves but not humans. The total protein of
human milk consists of approximately 40% of whey and 60% of casein, whereas cow's
milk consists of 20% whey and 80% casein (3). For human infants, whey is a more
digestible protein as compared to casein. A l,esser amount of casein in human breast milk
will produce a much softer and flocculent curd that can be easily digested by the infant's
digestive track. It is true that technology enables the manufacture to break down the size of
the curd produced by cow's milk to make it more digestible, but the quality of the protein in
human breast milk is better absorbed. Infants fed with infant formula will produce larger
stools, and these stools carry some of the nutrients out of the body.
Infant fonnula also often has sugar (sucrose) in it, and the combination of this
sugar and casein can cause necrotizing enterocolitis, a condition that can bring a fatal result
in infants (3). As a matter of foct, up to 8,000 infants in United States are affected by this
condition each year. In the premature infant, undigested sugar is fennented in the stomach
and becomes acidic. Then it win trigger an inflammatory reaction that actually can break
down the lining of the stomach. The final result can be intestinal rapture.. Several
symptoms of necrotizing enterocolitis are distended stomach, bloody diarrhea, fatigue, loss
of appetite and lower body temperature.
Another problem faced by premature infants is that the soy in soy-based fonnula
that is recommended for them might decrease iron uptake. Bone development I
mineralization in these infants is less compare to other fed with cow's milk base formula
(3). Not only that, soy-based fonnula is also deficient in iodine.
Some Problems Related to Trace Minerals in Infant
One case of aluminum toxicity in infants with abnormal kidney function has been
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reported in the 1983 by Randell (4). Even though this might not be dangerous for a nonnal
infant, there is no assurance whatsoever about its safety in a long tenn range.
In 1986, it was reported that the selenium content of infant formula was much
lower compared to human breast milk (3). It is suggested that infant formulas should be
supplemented by selenium. Due to the potential for selenium toxicity, supplementation
should be done very cautiously.
In 1990, the Committee on Nutrition of the American Academy of Pediatrics
recommended infant formulas to be fortified with iron even though in 1987 it was proven
that iron fortification can depress copper absorption in infant (3). It has been recognized
that copper content of human milk is two to three times higher than that of cow's milk.
The Increasing Trend Toward Bottle Feeding Instead Of Breast Feeding
As mentioned pr,eviously the increasing trend toward bottle feeding started in World
War n when more women worked away from horne (3). Since then, the trend has not
subsided. More women are a single parent now to their children, and to be able to
supporthem financially, they have to go to work. Short maternity leaves for these women
discourage them to breast fed their infants. In many countries, including the United States,
breast feeding infants in public is taboo. The number of designated places for breast
feeding is actually increasing in the last 10 years, but it still is not enough to encourage
working mothers to breast feed their infants.
Present Knowledge in Selenium, Manganese, Zinc, and Copper
Selenium
History
Selenium was discovered by Berzelius in 1817. It was recognize as a nutritionally
essential element in 1951 by a physician from Gennany named Klaus Schwartz. He
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worked for National Institutes of Health, found an unrecognized factor which he called
Factor 3, guards against necrotic liver degeneration. He later identified Factor 3 as
selenium due to the strong garlic odor it produced. Its biological toxicity was discovered in
1957 (5).
Selenium's biopotency went unnoticed for many years due mainly to the trace
amount needed to function and to the unavailability of such equipment at that time to detect
that very small amount.
Roles and Function
A study by Dr. Yang in China brought some strong suggestion of the important
function of selenium in Keshan disease (5), an endemic cardiomyopathy of unknown
cause, during 1974-1977 in Sichuan province. A supplementation in a form of sodium
selenite was given and proved to prevent further spread of the disease.
Selenoproteins have been identified: glutathione peroxidase, 5'-deiodinase type I
(6), and se]enoprotein P. In addition to that, selenium reportedly contains transport RNA
(tRNA).
The first suggestion of an involvement of selenium and glutathione peroxidase
(often abbreviated as GSH-Px) was stated by Tsen and Tappel in 1958 (7), where it was
suggested that selenium was tightly bound to the enzyme and that glutathione peroxidase is
a selenoprotein. The function of glutathione peroxidase in-vivo, primarily to metabolize
hydrogen peroxide, thus protects against injury. The latest study by Vadhanavikit and
Ganther in 1993 (6) mentions that glutathione peroxidase helps to protect the thyroid gland
from hydrogen peroxide that is needed to synthesis tyroxine (T4), a thyroid hormone.
When rats were fed with selenium-deficient diet, the activity of glutathione peroxidase in
liver and plasma was reduced to less than 1% (8). This means that the measurement of
glutathione peroxidase activ~ty can be used in assessing selenium nutritional status in
human.
Another selenoprotein, 5'deiodinase type I, is a major enzyme that catalyzes the
deiodination process where Tyroxine (T4) is converted to Triiodothyronine (T3), an active
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form of thyroid gland (6).
Another selenoprotein present in the human body is called selenoprotein P. The
function is not known, but since o~her selenoproteins have a reduction-oxidation function,
selenoprotein P might also has the same property. One hypothesis suggests that it has an
antioxidant function like vitamin E.
The role of selenium in pancreatic function was mentioned in several studies where
selenium deficiency is related to fibrotic degeneration of the pancreas in the chick
(9,10,11,12). Table IT will list the influences selenium has on pancreatic function. Two
studies in particular mentioned the effect of selenium compounds on cancer cells. In 1966,
Shamberger and Rudolph (13) found that topical selenite retarded the appearance of tumors
more effectively compared to vitamin E or other kinds of antioxidants. Another study done
by Weisberger and Suhrland in 1956 showed a remission in acute leukemia and chronic
myeloid leukemia after the patients received selenocystine (14,15).
Selenium is also associated with immunity. In two studies done by Spallholz et 311
in 1973 and 1975 (16,17) injection of selenium as selenite and selenium and vitamin E as
Seletoc® (5 Jlg Se/mouse) enhanced primary as well as secondary anti-sheep red blood cell
(SRBC) IgM and IgG antibody titers. The group of mice fed a diet containing selenium as
selenite 1-3 ppm had higher antibody titers.
Selenium, as a component of glutathione peroxidase, may also have the ability to
protect membrane from damage caused by lipid peroxide-induced cellular damage by
destroying that peroxide by catalyzing the reduction of lipid hyperoxides to the
corresponding alcohol derivatives (18).
A study by Wu et aI. in 1973 (19) showed that a female rat fed with a sel~nium­
deficient diet gave birth to male rats that had a very few spermatozoa recoverable from
cauda epidedymes. The motility of the spermatozoa was very poor and there was a
breakage between the body of the spennatozoa and the tail. In this case, vitamin E or other
antioxidants cannot replace selenium in solving the problem. Brown and Burke (1973)
showed that selenium is concentrated in the mid-piece of spermatozoa (20). A
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Table II. Influence of Selenium on Pancreatic Function (a) ..
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a From Thompson and Scott (1970).
b Significance difference, P < 0.05.

















selenoprotein plays a major role in keratinized process in sperm mid-piece.
Deficiency in Human and Animal
As we start to understand the important roles selenium has in the human body, it is
obvious that the greatest health risk of selenium deficiency is present among infants and
young children.
In late 1970s, a study in one province in China reported two human diseases
associated with selenium deficiency (21). Those diseases are juvenile cardiomyopathy
(used to be called Keshan disease), and chondrodystrophy named by its founder
Kaschinbeck disease. The affected areas have a very low selenium concentration in their
soil which leads to an extremely low selenium concentration in their foods.
Keshan disease is a multifocal inflammation of heart muscle that occurs primarily in
children aged 2 to 10 years old, and in some women of child-bearing age. The diagnosis
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of this disease is based on acute and chronic insufficient cardiac function, cardiomegaly,
and abnormalities in electrocardiogram and radiogram. Some patients show cardiogenic
shock or congestive heart failure and embolic episodes from cardiac thromboses. The heart
is the major organ that is affected by the disease, but some patients may also have hepatic
congestion, mesenteric lymphadenosis, degenerative diaphragm changes, and pancreatic
exocrine dysfunction. When infants start eating solid food, their selenium intake decrease
subtantiaUy due to an extremely low selenium content in food items. This is the time when
the first sign of deficiency is observed. The severity of the disease can be reduced by
giving the patients oral selenium supplementation.
Kaschin-Beck disease is an osteoarthropathy that affects primarily the epiphyseal
and articular cartilage and the epiphyseal growth plates of the growing bones. The affected
cartilage shows atrophy and necrosis with repair and endochondral ossification. The most
striking condition is chondronecrosis with proliferation of surviving chondrocytes in
clusters. This condition leads to enlargement of the joints (fingers, toes, elbows, and
knees); shortened fingers, toes, and extremities. Dwarfism is the result in severe cases.
The prevalence of the disease is greatest among children aged 6 to 15 years old. Since the
relation between this disease and selenium deficiency is less certain compared to Keshan
disease, lirni.ted studies suggest that oral selenium supplementation may be an effective way
to cure the disease. A more rigorous testing is needed.
A combination of selenium deficiency and vitamin E deficiency causes liver
necrosis in rats and swine, exudative diathesis in chickens, and in sheep and cattle white
muscle disease. A study done by McCoy and Weswig in 1969 (22), showed that animals
fed with a selenium-deficient diet and adequate vitamin E had hair loss, growth retardation,
and reproductive failure. Another study by Thompson and Scott in 1970 (23) showed
pancreatic degeneration in chicks with a very severe selenium deficiency.
Toxicity in Human and Animals
In livestock, selenium toxicity will happen if the intake exceeds 4 to 5 Ilglg.
Chronic selenosis is characterized by cirrhosis, lameness, hoof malformations, hair loss,
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and emaciation (24). The most common signs of selenium intoxication are hair loss and
nails. In some areas, lesion of the skin, abnormal nervous system and teeth condition
were also observed.
Requirement and Recommended Intake
The National Research Council established an estimated safe and adequate daily
dietary intake of selenium for adult in 1980 to be 50 to 200 l1g (25). This number was
extrapolated from animal experiments due to very few data available from human
experiments. A survey was done and showed that Keshan disease was absent in the area
where the selenium intake was at least 19 flg in male and 13 Ilg in female (2l). This can be
considered to be the minimum amount of intake for human. According to Levander (26)
plasma glutathione peroxidase activity is maximized in individuals who received an
additional 30 Il-g of selenium to the 11 I!g of selenium from a daily habitual intake. The
total amount for a maximum glutathione peroxidase activity is then 41 J.lg. This number is
then multiplied and added to it the safety factor to make the total amount of 70 J.lg for male
and 551lg for female. The recommendations for children were extrapolated from the adult
values on the basis of body weight. The "normal" North Americans diet should fulfill this
amount without any trouble at all. Special cases may arise for people who lives in a certain
area which has an extraordinary low level of selenium in the soil and are unable to obtain
food from other places.
The Recommended Dietary Allowance (Revised in 1989) for selenium is listed in
Table III.
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Table III. Recommended Dietary Allowance of Se (Revised 1989) in llglday.
Category Age (years) W,eight (a) Height (a) Se
lb m Jlgtd
Infants 0.0 - 0.5 13 24 10
0.5 - 1.0 20 28 15
Children 1-6 29 -44 35 - 44 20
7 - 10 62 52 30
Males 11 - 14 99 62 40
15 - 18 145 69 50
19+ 160 - 170 70 70
Females 11 - 14 101 62 45
15 - 18 120 64 50
19 + 128 - 143 65 55
Pregnant 65
Lactating 75
From Food and Nutrition Board, National Research Council: RDA 10th Ed..





Manganese was found to be a constituent of animal tissue in 1913. In 1931, Orent
and McCollum found that deficiency in manganese shown to induce growth retardation in
mice and an abnormal reproduction function in rat (27).
Roles and Function
Manganese has two major biochemical functions that are known at the present time.
Manganese is important as an enzyme activator and as a constituent of metalloenzymes.
Several enzymes that need manganese for activation are hydrolases, kinases,
decarboxylases, and transferases (28). Not aU of these enzymes are manganese specific
enzymes, some of them can be activated by other element such as magnesium. Those that
we manganese specific enzymes includes glycosyltransferases and xylosyltransferases.
There are only few manganese metaHoenzymes, arginase, pyruvate carboxylase, glutamine
synthetase, and manganese superoxide dismutase.
Pyruvate carboxylase is important in carbohydrate metabolism and that means
manganese plays a major role in carbohydrate metabolism. According to White et al, (29)
manganese is an activator of insulin receptor protein kinase.
In 1970, Friedman and Rasmussen reported that manganese increases
gluconeogenesis from lactate in the perfused rat liver (30), but it is not clear where exactly
in the pathway manganese has its affect.
Manganese is recognized to be essential for normal connective tissue, skeletal, and
nervous system development (31). One most striking effect apparent following acute
manganese deficiency is ataxia and audiogenic seizures (32). On the other hand,
manganese toxicity leads to primarily neurological symptoms such as tremor, rigidity, and
haHucinations.
Manganese also is essential for the oxidation of water to 02 in the photosynthetic
process. Manganese is required for the catalyst of the four-electron oxidation of water
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within the active site of the complex: (Mn)
2H20 ---------> 02 + 4e- + 4H+
Deficiency in Human and Animal
In many species of animals, deficiency in manganese causes impaired growth,
skeletal abnormalities, depress reproduction function, ataxia in newborn, and defects in
lipid and carbohydrate metabolism (28). But in humans, deficiency in manganese is less
conclusive.
Toxicity in Human and Animal
Again in animals, overdoses of manganese leads to depressed growth, depressed
appetite, impaired iron metabolism, and abnormal brain function (28).
In man incidents of manganese toxicity are normally the result of chronic inhalation
of large amount of airborne manganese, and not from the diet. But it is not until 1930's
and 1940's that manganese toxicity was recognized as a potentially serious to human health
(33). In individual who are exposed to high manganese environment, the sign of toxicity
occur only after few months or few years. It is characterized by severe psychiatric disorder
resembling schizophrenia progressing to crippling neurological disorder similar to
Parkinson's disease.
Manganese toxicity altered carbohydrate metabolism. Rubenstein et al (34)
suggested a possible relationship between manganese and carbohydrate metabolism,
where an insulin resistant diabetic patient responded to oral doses of MnCl2 and decrease
the blood glucose level.
Requirement and Recommended Intake
There is no RDA for manganese, instead the estimated safe and adequate daily
dietary intake (ESADDI) is used as a guideline (Table IV). The value of ESADDI were set
mainly because most food manganese content fall within this range without producing
either deficiency or toxicity.
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Table IV. The Estimated Safe and Adequate Daily Dietary Intake for Mo.
Category Age (years) Mn (mg/day)
Infants 0-0.5 0.3 - 0.6
0.5 - 1 0.6 - 1.0
Children I - 3 1.0 - 1.5
4-6 1.5 - 2.0
7 - 10 2.0 - 3.0
11 - older 2.0 - 5.0
Adult 2.0 - 5.0
From Food and Nutrition Board, National Research Council: RDA 10th Ed.
Washington, D.C., National Academy Press, 1989.
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Hist0O'
In 1934, Todd et at (35) reported the essentiality of zinc for growth and well being
in rats for the first time. Tucker and Salmon (36) reported that zinc cures and prevents
parakeratosis in swine. Zinc deficiency in mao was suspected to occur for the first time in
1961 in Iranian males (37).
Roles and Function
Growth retardation in rats mentioned in Todd et aL study (35) was suggested to be
caused by a decrease activity of thymidine kinase that leads to impaired DNA synthesis and
cell division. In different study done by Mills et al.(38).lambs and calves given a severely
zinc-deficient diet ceased growth abruptly and within two weeks, growth stop. Pregnant
rats given a zinc-deficient diet had an impaired fetal growth while such a diet fed during
lactation impairs growth in suckling pups (39). Zinc deficiency in male human manifested
in dwarfism and hypogonadism. These characteristics first were studied by Prasad in Iran
and Egypt in 1960's (37). As soon as adequate zinc was provided. stimulation to growth
is resumed.
Growth retardation is also partly resulted from impaired appetite. The study done
by Chesters and Quarterman (40) showed that voluntary food intake of zinc-deficient rats
decrease up to 70% compare to control. When the rats were fed with zinc-supplemented
diet. nonnal eating pattern was obtained within two hours. Henkin and associates (41)
were the first group that establish the physiological role of zinc in normal taste sensation.
Further study showed that hypogeusia or loss of taste acuity and dysgeusia or disorder
taste can respond rapidly to zinc therapy.
Rats and mice with zinc deficient condition also suffer from alopecia and gross skin
lesions. Parakeratosis of epithelial cells and esophagus was also disclosed in histological
studies (42). In more severe condition, loss of hair, dermatitis, scaling and cracking of the
paws with deep fissures develop (43). The healing of all these conditions are very rapid
and dramatic. Acrodermatitis enteropathica, a hereditary disease caused by an abnormal
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zinc metabolism, responds very well to zinc supplementation.
Zinc deficiency also has a very detrimental effect on reproduction. The
development of the primary and secondary sex organ in male and spermatogenesis, and all
the reproductive phases in female affected by zinc deficiency. Retarded development of
testes, epididymis, prostate, and pituitary gland was reported along with atrophy of the
testicular germinal of epithelium by Mawson et aI.(44) In part of Iran and Egypt,
hypogonadism with the suppression of secondary sex organs were observed in young male
and young female (37).
Several species of bird show an abnormal skeletal development with zinc deficiency
(45). The long bones are shortened and thickened and the severity if proportional to the
severity of the deficiency. Supplementation of zinc clearly prevent this condition although
the nature of interaction remain obscure. In chick, osteoblastic activity is decrease in the
long bones,. together with a decrease in chondrogenesis in relation with an increase in the
amount of cartilage matrix (46).
The role of zinc in wound healing have produced conflicting results. This role was
first observed by Pories and associates (47) in the study where a young man, following a
surgery forpilonoidal sinuses, was given zinc sulfate (50 rng of zinc) three times a day.
His rate of wound healing was much faster compare to unmedicated patient. Several other
patients with severe bums and major surgery demonstrated improved wound healing. This
increase in spe,ed of wound healing causes by zinc may be explained in the fact that the
metabolic demand for this element in collagen synthesis in the process of tissue repair is
increased (48), but the direct evidence is lacking.
There has been an indication that zinc may have a beneficial effect in some cases of
atherosclerosis. Pories et al.(47) gave zinc sulfate to 13 patients with an advance vascular
disease for 29 months. Twelve of them showed a marked improvement and nine return to
a normal activity. The mode of action of zinc in atherosclerosis is unknown, but since
atherosclerosis is thought to start with some form of trauma it may be, in part, an
expression of inadequate arterial repair.
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The beginning of fifth week of pregnancy is a critical period for brain growth. Zinc
deficiency during this sensitive time will pennanently affects brain function. When this
deficiency is continue throughout the latter third semester of pregnancy. the brain size will
decrease. There is a reduce in total brain cell number and the cytoplasmic nuclear ratio is
increased which signs an impairment of cell division in the brain during macroneuronal
proliferation. Zinc deficient suckling rats have retarded brain maturation indicated with a
reduce total cerebellar lipid concentration, and a significantly lower rate of protein synthesis
in the brain (50). The same study showed that a delay in myelination is also found in rat
pups when zinc is deprived during gestational and lactation period that leads to a significant
reduction in rat brain 2',3'-cyclic nucleotide 3'-phosphohydrolase.
Zinc is involved in nucleic acid and protein metabolism which means it is important
in cell replication process. Zinc deficiency leads to an impairment of DNA synthesis ill the
liver (50) and reduce total protein and RNA contents of testes. Utilization of amino acids in
the synthesis process of protein impaired in zinc deficiency (51).
Prasad and associates (37) found in their study that several enzymes decrease their
activities when zinc level is reduced. In testes, lactic dehydrogenase (LDH), malic
dehydrogenase (MDH), alcohol dehydrogenase (ADH), and NADH diaphorase; in the
bone, LDH, MDH, ADH, and alkaline phosphatase; in esophagus, MDH, ADH, and
NADH diaphorase; and in the kidney, MDH and alkaline phosphatase were decreased.
Pancreatic carboxypeptidase activity was also found reduced in zinc deficient rats and
return lo normal rapidly with zinc therapy.
Deficiency in Human and Animal
The growth retardation found in zinc deficiency does not seems to be caused only
by decreased food intake. Study by Miller et a1.(52) showed that young pigs given zinc-
deficient diet declined in their body weight even before food intake was affected. Nutrients
utilization was impaired perhaps due to changes in enzyme activities caused by zinc
deficiency. Paired-feeding in rats also showed a similar result. The same amount of food
was given to both group, but the group given a zinc-deficient diet had significantly lower
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body weight compare to the other group.
Zinc was found in smaU amount in crystalline insulin. When glucose was injected
intraperitoneally into rats with a low zinc-deficient diet for a longer period of time, their
glucose tolerance of these rats was depressed (53). ]t is believed that the rate of insulin
secretion in response to glucose ingestion is decreased in zinc deficiency.
The effect of zinc deficiency in growth and sex hormones was observed in in-vitro
studies with human cell culture. Injection of gonadotropin and testosteron, under zinc
deficiency condition, promote male accessory sex organs but did not prevent testes tubular
atrophy (54).
Zinc has been shown to be a structural component of severa] metaUoenzymes and
plays a functional role in some of them. In the case of deficiency, it is suspected that the
activity of those enzymes wHi change. The study done by Guttikar et al.(55) showed that
serum alkaline phosphatase level is not affected by calorie intake, on the other hand its
activity loss is directly attributed to zinc deficiency. Other enzymes such as pancreatic
carboxipeptidases, which are important in protein digestion, loss its activity in zinc
deficiency. Prasad and Oberleas (56) has done some studies to see if zinc status will
change the activity of alcohol dehydrogenase. The studies showed clearly that zinc
deficiency lowers the activity of this enzyme in the liver, bones, testis, kidneys, and
esophagus in rats and pigs. Zinc deficiency also may affect RNA and DNA metabolism in
organisms and plants which then responsible for impaired protein synthesis (57).
Toxicity in Human and Animal
Three studies in late 1960 and early 1970 suggested three types of zinc toxicity in
human. First type of toxicity, metalfumefever, was observed in some industrial workers
who are exposed to the fumes, and the symptoms are fever and gastroenteritis. The second
type was observed in a 16-year old boy who ingested 12 mg of Zinc sulfate within 2 days,
and the symptoms are lethargy, increased serum lipase and amylase levels (58). The third
type has been observed in a patient with renal failure following hemodialysis (59), and the
symptoms are nausea, vomiting, fever, and severe anemia.
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An animal study was done by Van Reen (60) showed that rats ingested 0.5-1.0%
zinc have a reduced growth, anemia, poor reproduction, and a decreased activity of liver
catalase and cytochrome oxidase. This condition can be reversed by s1llpplementing the rats
with copper. This suggest that zinc toxicity may cause copper deficiency.
Requirement and Recommended Intake
The 1989 RDA for zinc are based on the intakes required to maintain balance and to
replace endogenous losses. The revised RDA is listed in Table V.
Table V. Recommended Dietary Allowance for Zn (revised 1989) in mglday.
Category Age (years) Males Females
Infants 0.0 - 0.5 5 5
0.5 - 1.0 5 5
Children 1 - 3 10 10
4-6 10 10
7 - 10 to 10
Adolescents 11 - 18 15 12
Adults 19-51+ 15 12
Pregnancy 15
Lactation First 6 months 19
Second 6 months 16
From Food and Nutrition Board, National Research Council: RDA 10th Ed.




Copper was therapeutically used around 400 BC. It was prescribed for pulmonary
and other diseases (61).. The thought that copper is essential to human body was not exist,
not until the second decade of the century following the discovery of several vitamins. In
1928 an animal study showed a certain kind of anemia that could not be prevented by iron
supplement only. This anemia was responsive to iron only if copper supplement was also
given at the same time. Copper was link to human disease for the first time around 1912,
when Wilson's disease was described, but a conclusive evidence of copper deficiency was
not reported until 1964.
Roles and Functions
Copper is an important part of many enzymes and proteins (62). Severa) copper-
containing enzymes found in human beings are: monoamine oxidase (involved in
inactivation of catecholamines), diamine oxidase (inactivates histamine, polyamines), lysyl
oxidase (play role in the formation of connective tissue}, ceruloplasmin (catalyzes the
oxidation of ferrous iron, transfer iron from storage site for hemoglobin synthesis),
ferroxidase II (catalyzes the oxidation of ferrous iron), cytochrome c oxidase (reduces
oxygen to form water), dopamine B-hydroxylase (catalyzes the convertion of dopamine to
norepinephrine), extracellular superoxide disrnutase (scavenges superoxide radicals and
protect against oxidative damage), copper/zinc superoxide dismutase (protect intracellular
from oxidative damage), tyrosinase (catalyzes the convertion of tyrosine to dopamine and
the oxidation of dopamine to dopaquinone, also required for melanin synthesis).
Some physiological functions of copper are also well known (61). Copper,through
lysyl oxidase, plays an important role in collagen and elastin cross-linking. Collagen and
elastin are required to make a strong yet flexible connective tissue. Copper, as a
component of ceruloplasmin and ferroxidase II, is essential in the formation of bone
marrow cells necessary for red blood cell synthesis. In central nervous system, copper is
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required for the formation and maintenance of myelin sheet.
Deficiency in Human and Animal
Copper deficiency has been observed particularly in human infants (61). Premature
infants, infants 6 to 18 months, or those recovering from marasmus on exclusive milk diet
are susceptible to copper deficiency. The major manifestation of copper deficiency are:
neutropenia, hypochromic anemia, osteoporosis with the enlargement of costochondral
cartilages (scurvy-like condition), decrease pigmentation of the skin, chronic diarrhea, and
in later stages, neurological abnormalities such as hypotonia, apnea, and psychomotor
retardation.
Toxicity illl Human and Animal
Oral ingestion of excess copper causes a metallic taste in the mouth, nausea
vomiting, epigastric pain, diarrhea, a variable degrees of jaundice, hemolysis,
hemoglobinuria, hematuria, and oliguria. In some severe cases, anuria, hepatic necrosis,
vascular collapse, hypotension, coma, and death can occur (61). Hemolysis, due to an
excess copper in red blood cells, may inhibit erythrocyte glycolysis, glucose-6-phosphate
dehydrogenase, oxidation of glutathione, and denaturation of hemoglobin.
Copper toxicity in young infants, under normal circumstances, has been reported,
presumably exposed via drinking water, cooked food, and contamination from all-copper
containers (61). Renal patients undergo dialysis are also prone to copper toxicity.
Requirement and Recommended Intake
Mason (61), in his article, defined the term of minimal intake as the daily intake
which equals the daily excretion. To know exactly how much copper is needed by human
body is difficult to establish due to several factors such as the' variability of the amount
actually being absorbed by the body, slow rate of turnover, and exclusive output via the
feces. But, nevertheless, a guideline has been established by the National Research
Council of the United States concerning copper requirement intake. The Estimated Safe
and Adequate Daily Dietary Intake tor cooper is listed in table VI.
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Table VI. The Estimated Safe and Adequate Daily Dietary Intake for Cu in
mg/day.
Category Age (years) Amount (rog/d)
Infants 0.0 - 0.5 0.4 - 0.6
0.6 - 1.0 0.6 - 0.7
Children 1 - 3 0.7 - 1.0
4-6 1.0 - 1.5
7 - 10 l.0 - 2.0
11+ 1.5 - 2.5
Adults 1.5 - 3.0
From Food and Nutrition Board, National Research Council:




Selenium, manganese, zinc and copper content of sixteen different commercially
prepared infant formulas were detennined. The sixteen fonnulas represent six basic
formula names, but these six have different major constituent sources (soy protein and cow
milk), they differ within brand names according to iron content (low iron or added iron),
form (ready-to-feed, concentrated or powdered), and formula storage environment (metal
cans or glass bottles). Details are listed in Appendix A.
This chapter describes the selection of infant formulas, labeling the formula to be
used, preparation for analysis, sampling, wet ashing, and atomic absorption
spectrophotometry. The data were then statistically analyzed.
Labeling The Infant Formula to be Used
Random Selection From Each Lot
From each lot for each formula, two or three containers were randomly selected.
They were, then, labeled by letter chronologically, A through p. according to their
expiration date to insure that no analysis would represent an outdated formula. Since two
or three containers were taken from each lot, additional secondary numbers representing
these, accompanied each letter, for example AI, A2, A3, B 1, and so on. Thus, after
samples were taken, there was no direct identification of letter assigned to a particular
formula. Appendix B gives a listing of formulas and detailed infonnation such as lot







From each can or bottle, four samples were taken for mineral analyses. Since two
or three cans or bottles (depending on numbers in the lot; see Appendix IT) were taken from
each of the 16 lots to make the total of 40 cans or bottles, the total samples taken were 160.
For mineral analyses, regular glass test tubes were used to hold the samples.
* Three hundreds of these glass test tube were acid washed for at least 24
hours to make sure that all the test tubes were clean from any kind of
minerals that can and will distorted the result of the mineral analyses.
Mter being soaked for at least 24 hours in acid bath, the tubes were then
washed with distilled water to rinse off all the acid. Distilled water from
the same source was used in preparation of the infant formulas.









The mouth of the test tubes were then covered with parafilm (Parafilm
"M"@ laboratory film; American National Can; Greenwich, CT. 06836) to
avoid contamination.
The test tubes were marked with ceramic marker and let dry for 10 to 15
minutes.
The test tubes were put upside down inside a 500 mL acid washed beaker
covered by acid washed petri dish.
Again the beakers were put in the oven over night at lOD0e.
The test tubes were taken out the next day and let cool down at room
temperature.
The test tubes were weighed.
When all the test tubes were ready, the sampling began.










All sampling process was done under the hood to avoid contamination.
The container of all liquid formula were thoroughly shaken to distribute the
precipitation that occured during storage.
The tops of the containers were rinsed with distilled water and wiped dry
with Kim Wipe.
If the particular infant formula is a ready to feed formula, no distilled water
was added.
For concentrated formula, 10 mL of the formula was diluted with distilled
water according to the manufacture to be ready to use.
For powdered formula, one spoon, using the spoon provided with the
formula which was inside the container, was used and diluted with distilled
water according to the manufacturer to be ready-to-used.
Four samples were taken from each of the formulas using a 1000 ilL
micropipette, placed in the prepared test tube, and covered with parafilm to
avoid contamination.
After all the sampling was done, the test tubes, again, were covered with
parafilm to avoid contamination.
All sampling procedures except for rinsing of the container top were carried under
the hood.
Ashing Procedure




Since the space in heating block for wet ashing was limited (96 test tubes at
one time), the samples were divided into two groups. While the first half
was in the heating block, the second half was stored in the freezer.





was placed in the heating block with each run to serve as the control and
was treated identicaUy to the samples (see Appendix C), and treated the
same way as other tubes containing the sample.
Distilled water (the same distilled water used during the previous steps).
nitric acid (Lot # R17), and hydrogen peroxide (Lot # C40338) were used
for wet ashing.
500 I,1L of nitric acid was added to each test tube.
The test tubes were then put in the heating block at 800 C overnight.
Appendix A shows the configuration of the test and control tubes in the





The following day :
a. The temperature was increased to l000 C
b. 250 J1L of hydrogen perox.de after all but about 1 mL
of solution had evaporated from all tubes.
c. 100 ilL of hydrogen peroxide was added every two hours for
one week until the dry crystal left in the tube was pure white in
color.
If one of the tubes (either test tube or control tube) was dry the next day,
100 ilL of distilled water, nitric acid, and hydrogen peroxide were added to
all of the tubes, including the one that was not dry. Then, 50 ilL of
hydrogen peroxide was added every two hours instead of 100 l-LL.
When all the tubes were ready, the heating block was turn off.
All the tubes were, then, again stored inside an acid washed beaker and petri
dish and stored inside a plastic container.
The second half was the put in the same heating block with the same
treatment as the first half.
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* After all the samples cooled to room temperature, they were weighed
again to detennine the dry sample weight after wet ashing. They were all





The acidity of each infant fonnula was measured with Fisher Accumet® Model
815MP pH Meter immediately after all the sampling was done. The test was done directly
in the original can or bottle of each infant formula at the same room temperature of 260 C.
The results were also listed in Appendix D.
Atomic AbsorptiQn Procedure
* Four minerals were quantified with the Atomic AbsQrption
Spectrophotometer (perkin-Elmer 5100pe GFAAS - Zeman). Zinc and
copper were measured on the flame side and manganese and selenium Qn
furnace side.
All the dry samples in glass tubes were diluted with 200~ Qf concentrated
nitric acid and 1.3 rnL of distilled water. Since tbe volume of original
sample was 1000 ~L and nQW it was diluted to 1500 ilL, the original
dilutiQn factor Cdf) is, then, 1.5. The mixture was then vortexed vigorously
befQre it was poured to a sterile pQlyetheline tube (Falcon® Too) of
DiscQvery; Becton Dickinson Labware; Lincoln Park, NJ. 07035) before
being stored in the refrigerator.
For copper and zinc, the original dilution factor was used for the analyses.
For manganese: 50 ~L of original sample was added with 3.0 mL of 0.5%
of nitric acid.
df =[(50 ~L + 3.0 mL) : 50 JlL] x 1.5 =91.5
* For Selenium:




500~ original solution (df=1.5) was added with 750 ~L of 0.5% nitric
acid. The new df=3.75.
For each tube, four new sterile polyetheline tubes were labeled (e.a.: 23-1,
23-2, 23-3, 23-4).
On all tubes labeled -1, 250 J.lL of 0.5% nitric acid was added.
On all tubes labeled -2, 250 J1L of 50 ppb selenium standard was added.
On all tubes labeled -3, 250 !J.L of 100 ppb selenium standard was added.
On all tubes labeled -4, 250 J.1L of 150 ppb selenium standard was added.
The result of the analysis can be found in Appendix E.
During all the preparation for analysis, hair net, laboratory coat, and mineral-free
gloves were used at all time to prevent contamination.
Statistical Analysis
A simple descriptive statistic analysis is used (mean, standard deviation, and range)
to analyze the data in this study. Limited number of samples from different lots prevented




Trace Minerals Content of Infant Formula Compared to Breast Milk
Data were analyzed to determine zinc, copper, manganese, and selenium content in
various infant formulas. The mean concentrations of zinc and copper in various infant
formulas were determined for comparison with values reported by the manufacturer and for
comparison with the concentrations in breast milk reported by the Committee on Nutrition
of the American Academic of Pediatrics 1985 (2). The mean concentrations of manganese
and selenium in various infant fonnulas were determined for comparison with thevalue in
breast milk reported by the Committee on Nutrition of the American Academic of Pediatrics
1985.
Tables VII to X summarize the mean concentrations of zinc, copper, manganese,
and selenium from the infant formulas. The standard deviations from the mean ( SD ) and
the highest and lowest values from each infant formula are also shown along with the actual
concentrations range of zinc reported by the manufacturer and the concentrations in breast
milk ( ±SD). The ratio between the value from the experiment and from breast milk is
shown in figure I to IV.
After comparison was made between the content of zinc in various infant formulas
being tested and the content of zinc in breast milk, it was clear that the zinc content of infant
formula was 4.2 to 8.5 times higher than that was in breast milk. Infant fonnula being
tested contained 2.2 to 6.9 times more copper than breast milk. The infant formulas
contained a wide range og manganese. It ranged from 8.2 to 55.00 times that of breast
milk. For selenium, infant formulas contained 1.8 to 3.3 times more selenium than breast
milk.
Zinc and copper content of infant fonnulas made from cow milk and soy bean were
similar. For manganese,. infant formulas made from soy bean consistently had a higher
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concentration when compared to those made from cow milk. Computer analysis showed
that 1 cup (186 g) of dried soy bean contains 4.69 mg of manganese while 1 cup (244 g) of
cow milk contains only 0.01 mg. For selenium, the differences between infant fiormulas
made from soy bean and cow milk were not as great, but still consistantly higher in those
made from soy bean. Computer analysis again showed that 1 cup (186 g) dried soy bean
contains 10.6 I-lg of selenium while I cup (244 g) of cow milk contains only 3.0 Ilg.
Trace Minerals Intake from Infant Formula Tested Compared to the Latest
Recommendations
Table XI to XIV again summarize the mean value of zinc, manganese, copper, and
selenium ± SD from the analysis, the latest recommendation for each mineral (RDA and
ESADDI) for age group 0 - ] year old, the infant average intake of each mineral in one day
when the infant consumes only formula and not breast milk. The ratio between the
recommendation and the intake is shown in figure V to VITI.
For zinc, the Recommended Dietary Anowance (1989) for age group 0 - 1 year old
is 5 mg/day. According to Fomon SJ, et aL (1), average infants consume 16 to 32 f).oz. of
milk in one day. When those numbers were used to calculate the intake of mineral from
infant formula being tested, on a daily basis infants get between 0.47 to 1.93 times the
RDA for zinc from infant formula.
For copper, the Estimated Safe and Adequate Daily Dietary Intake for age group 0 -
1 year old is between 0.4 to 0.6 mg/day. Again when the results were calculated using the
average amount of milk consumed in one day, infants would get between 0.43 to 2.7 times
of the ESADDI for copper from the infant formulas being tested.
For manganese, the Estimated Safe and Adequate Daily Dietary Intake for age
group 0 - I year old is between 0.3 to 1.0 Ilg/day. The ratio between the intake of
manganese from infant formulas being tested ranged between 0.02 to 0.31 times the
ESADDI for manganese.
For selenium, the Recommended Dietary Allowance (1989) for age group 0 - 1 year
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old is 10 to 15 ~glday. The ratio between the intake of selenium from infant fonnula being
tested is ranged between 1.12 to 4.15 times he RDA for selenium.
Since there were not enough sample ava.lable for the experiment. the significant of
the results of the experiment cannot be determined. The result reported above should be
used to guide further study towards any of these trace minerals to see if they are
consistently high in all infant formulas avaitlable in the market and not only in certain lots.
An absorption study then can be done to see the significance of this different level of trace
minerals in infant formula compared to breast milk to see if the excess of trace minerals in
infant formula is all being absorbed or not
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Table VII. Zinc Concentration of Prepared infant Formulas: Analyzed. and
Manufactured.
Sample Analyzed Printed on
n Concentration (a) Range (b) Label (c)
ALIMENTUM®-Protein 12 5. 12±0.45 3.79-5.57 5.07
Hydrolysate wlIron (ready)
STh1ILAC®PM60/40-Low !l 5.63±O.30 5.08-5.98 5.07
iron (ready)
SIMILAC®-Low Iron (ready) 12 5.27±0.46 4.39-5.86 5.07
ISOMIL®-Soy formula w/Iron 11 5.26±0.32 4.50-5.76 5.07
(ready)
SIMILAC®-Specia] Care wlIron 12 1O.20±0.69 8.66-10.96 10.14
(ready)
SIMILAC®-w/lron (concentrated) 10 5.28±0.21 4.76-5.47 5.07
SIMILAC®-Low Iron (cone.) 12 5.13±0.92 2.17-5.81 5.07
SIMILAC®-wlIron (ready) ]2 5.08±0.46 3.78-5.44 5.07
ISOMIL®-Soy formula w/Iron 8 5.23±0.39 4.50-5.85 5.07
(concentrated)
ISOMIL®-Soy formula wlTron 8 5.46±0.3l 4.80-5.85 5.07
(ready)
SIMILAC®-wlIron (ready) 8 5.27±0.68 3.84-5.84 5.07
SIMILAC®-wlIron (ready) 8 5.30±0.19 4.80-5.39 5.07
SIMILAC®-Low Iron (powder) 8 5. 19±0.09 5.02-5.32 5.07
SIMILAC®-wllron (powder) 8 5.15±0.55 3.76-5.56 5.07
SIMILAC®PM60/40-Low Iron 8 5.23±0.33 4.82-5.69 5.07
(ready)
ISOMIL®-Soy formula w/lron 8 5.05±0.28 4.62-5.39 5.07
(powder)
Zinc concentration of breast milk = 1.2 ± 0.2 mg/l (2).
a Mean ± SO in mg/I.
b Range in mg/I.
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Table VIn. Copper Concentration of Prepared infant Fonnulas: Analyzed and
Manufactured.
Sample Analyzed Printed on
n Concentration (3) Range (b) Label (c)
ALIMENTUM®-Protein 12 0.63±0.04 0.50-0.68 0.51
Hydrolysate wllron (ready)
SIMILAC®PM60/40-Low iron 11 0.62±0.03 0.57-0.66 0.61
(ready)
SIMILAC®-Low Iron (ready) 12 0.62±0.03 0.56-0.65 0.61
ISOMIL®-Soy formula wlIron 11 0.58±0.14 0.29-0.64 0.51
(ready)
SIMILAC®-Special Care wlIron 12 1.73±0.13 1.38-1.84 1.69
(ready)
SIMILAC®-wlIron (concentrated) 10 0.61±0.16 0.20-0.76 0.61
SIMILAC®-Low Iron (cone.) 12 0.63±0.08 0.41-0.&0 0.61
SIMILAC®-wlIron (ready) 12 0.61±0.04 0.54-0.66 0.61
ISOMIL®-Soy formula wlIron & 0.56±O.09 0.34-0.63 0.51
(concentrated)
ISOMIL®-Soy formula w/Iron 8 0.53±0.03 0.54-0.63 0.51
(ready)
SIMILAC®-wlIron (ready) 8 0.62±0.11 0.34-0.66 0.61
SIMILAC®-wlIron (ready) 8 0.60±0.04 0.56-0.66 0.61
SIMILAC®-Low Iron (powder) 8 0.66±0.05 0.59-0.72 0.61
SIMILAC®-wlIron (powder) 8 0.63±0.03 0.59-0.67 0.61
SIMILAC®PM60/40-Low Iron 8 0.64±O.21 0.22-0.82 0.61
(ready)
ISOMIL®-Soy formula wlIron 8 0.54±O.02 0.53-0.58 0.51
(powder)
Breast milk copper concentration =0.25 ± 0.03 mg/! (2).
a Mean ± SD in mg/L
b Range in mg/l.
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Table IX. Manganese Concentration of Prepared Infant Formulas: Analyzed.
Sample n Concentration (a) Range (b)
ALIMENTUM®-Protein Hydrolysate 11 245+9.84 235-268
wlIron (ready)
SIMll..AC®PM60/40-Low iron (ready) 10 48.91±4.58 43-57
SIMILAC®-Low Iron (ready) 10 81.92+7.74 78-96
ISOMll..®-Soy formula wlIron (ready) 11 225±39.70 196-282
SIMILAC®-Special Care wlIron (ready) 12 70±31.50 124-214
SlMILAC®-wlIron (concentrated) 11 65.73±5.24 56-70
SlMILAC®-Low Iron (concentrated) 12 52.25±2.75 48-58
SIMILAC®-wlIron (ready) 10 55.50±W.74 45-80
ISOMIL®-Soy fonnula wlIron (cone.) 6 295±13.34 266-305
ISOMIL®-Soy formula wllron (ready) 8 304.88±4.01 299-313
SIMILAC®-wlIron (ready) 8 62.63:t4.59 53-74
SIMILAC®-wlIron (ready) 8 61.25±6.28 49-68
SIMILAC®-Low Iron (powder) 6 60.50±11.21 46-81
SIMll..AC®-wlIron (powder) 8 66. 13±9. 17 55-89
SIMILAC®PM60/40-Low Iron (ready) 8 69.00±5.83 62-78
ISOMIL®-Soy formula wlIron (powder) 8 329.88+6.94 321-343
Manganese content of standard milk from National Bureau of Standards Certificate of
Analysis = 260 ±...60 Ilg!l and from the test = 277 ± 52 Ilgll.
Breast milk manganese concentration = 6 ± 2 ~g/l (2).
a Mean ± SD in j.lgll.
b Range in j.lgll.
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TableX. Selenium Concentration of Prepared Infant Formulas: Analyzed.
Sample n Concentration (a) Range (b)
ALIMENTUM®-Protein Hydrolysate 6- 35.33±3.40 30 -40
wlIron (ready)
SIMILAC®PM60/40-Low iron (ready) 6 41.67±2.21 39 -45
SIMILAC®-Low Iron (ready) 6 50.67±3.68 45 - 57
ISOMIL®-Soy formula wlIron (ready) 6 53.83±2.12 50 - 57
SIMILAC®-Special Care wlIron (ready) 6 59.00±3.92 53 - 64
SIMILAC®-wlIron (concentrated) 6 46.33±2.36 44 -50
SIMll...AC®-Low Iron (concentrated) 6 45.83±2.40 42 -49
SIMILAC®-wlIron (ready) 6 48.50±2.57 45 - 51
ISOMIL®-Soy formula wlIron (cone.) 4 63.50±2.29 60- 66
ISOMIL®-Soy formula wllron (ready) 4 63.50±2.25 62 - 67
SIMILAC®-wlIron (ready) 4 55.50±3.57 51 - 59
SIMILAC®-wlIron (ready) 4 62.00±4.64 55 -68
SIMILAC®-Low Iron (powder) 4 55.75±2.68 53 - 60
SIMILAC®-wlIron (powder) 4 64.00±1.23 62 - 65
SIMILAC®PM60/40-Low Iron (ready) 4 66.00±4.64 61 -72
ISOMIL®-Soy formula wflron (powder) 4 50.00±4.12 47 ~57
Selenium content of standard milk from National Bureau of Standards Certificate of
Analysis =110 ± 10 J..lg/l and from the test =102 ± 15 flgll.
Breast milk selenium concentration = 20 ± 5 J.lg/l (2).
a Mean ± SD in f.lg/l.
b Range in Jlgll.
39








4 I"":' ,.,... s::
:.:.
r::-: r:-:- '? 0:-: .-::- 7: 0::










.:.,. ,', ::::.: ".:' :.:- ": . '.:.,
~:.::
0.:' : '.:..: ..~. :.:. ~.:.~.. .', " : >::. .o.:. . ,":: ',:"' '::' ," :.:. '.n ". .: ::-. ',:'. :<: :.::.: :.:. .-.:..: :: ::. ",:'. :.,', '.: " : :,0, 0:, '., .'
x A B C D E F G H I J K L M N 0 P
Breast milk =1.2 ± 0.2 mg!l (2).
Each letter represents an infant formula (see Appendix B).
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Breast milk =0,25 ± 0.03 mg!l (2).
Each letter represents an infant formula (see Appendix B)
The content in breast milk.












The Ratio between Manganese Content in Infant Formula and Breast Milk.
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Breast milk = 6 ± 2 Ilg/l (2),
Each Jetter represents an infant formula (see Appendix B)
The Ratio between Selenium Content in Infant Formula and Breast Milk,
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x
A to P
Brea~t milk = 20 ± 5.0 j..lg/l (2).
Each letter represents an infant formula (see Appendix B)
D
CJ
The content in breast milk.
The content in infant formulas,
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Table XI. Comparison of the RDA for Zinc for Age Group 0-1 Year Old
(5 mg/d) and the Estimated Amount Typically Consumed (mg/d) from
Infant Formulas.
Sample Concentration Estimated Intake, mgld (a)
(±SD), mgfl (16-32oz./d)
ALIMENTUM®-Protein Hydrolysate 5.12 (±0.45) 2.42 - 4.83
wlJron (ready)
SIMILAC®PM60/40-Low iron (ready) 5.63 (±0.30) 2.66 - 5.31
SIMILAC® Low Iron (ready) 5.27 (+0.46) 2.49 - 4.97
ISOMlL®-Soy fonnula wllron (ready) 5.26 (±O.32) 2.48 - 4.96
SIMILAC®-Special Care wllron (ready) 10.20 (±O.69) 4.82 - 9.65
SIMILAC®-wllron (concentrated) 5.28 (±0.21) 2.49 - 4.98
SIMll.AC®-Low Iron (concentrated) 5.13 (±O.92) 2.42 - 4.84
SlMll.AC®-wllron (ready) 5.08 (±0.46) 2.40 - 4.80
ISOMIL®-Soy formula wllron 5.23 (±0.39) 2.47 - 4.93
(concentrated)
ISOMlL®-Soy fonnula wlIron (ready) 5.45 (±0.31) 2.57 - 5.15
SIMlLAC®-wllron (ready) 5.26 (±0.68) 2.49 - 4.97
SIMlLAC®-wllron (ready) 5.30 (±0.19) 2.50 - 5.00
SIMlLAC®-Low Iron (powder) 5.18 C±0.09) 2.45 - 4.89
SIMLAC®-wllron (powder) 5.15 (±0.55) 2.43 - 4.86
SlMlLAC®PM60/40-Low Iron (ready) 5.23 (±0.33) 2.47 - 4.93
ISOMIL®-Soy formula wllron (powder) 5.05 (±0.28) 2.38 - 4.77
a The average intake in one day in mg.
The average amount of milk consume by infant age 0- I year old is between
16 - 32 fl.oz.
16 fl. oz. =16 fl.oz. x 29.5 mllfl.oz =472 ml =0.4721
32 fl. oz. =32 fl.oz. x 29.5 mllfl.oz =944 rol =0.944 1
The intake of mineral in mg/d = 0.472 1x amount of mineral (mg/l).
= 0.9441 x amount of mineral (mgll).
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Table XII. Comparison of the ESADDI for Copper for Age Group 0-1 Year Old
(0.4-0.6 mg/d) and the Estimated Amount Typically Consumed (mg/d) from
Infant Fonnulas.
Sample Concentration Estimated Intake, mg/d (a)
(±SD), mgll (16-32oz.ld)
ALIMENTUM®-Protein Hydrolysat.e 0.63 (±0.04) 0.29 - 0.59
wlIron (ready)
SIMILAC®PM60/40-Low iron (ready) 0.62 (±0.03) 0.29 - 0.59
SIMJLAC®-Low Iron (ready) 0.62 (+0.03) 0.28 - 0.59
ISOMIL®-Soy formula w/Iron (ready) 0.57 (±0.14) 0.27 - 0.54
SIMILAC®-Special Care wlIron (ready) 1.72 (±0.13) 0.81 - 1.62
SIMILAC®-wlIron (concentrated) 0.61 (±0.16) 0.29 - 0.57
SIMILAC®-Low Iron (concentrated) 0.63 (±0.08) 0.30 - 0.59
SIMILAC®-wlIron (ready) 0.61 (±0.04) 0.29 - 0.58
ISOMll..-®-Soy formula wlIron 0.56 (±0.09) 0.26 - 0.53
(concentrated)
ISOMIL®-Soy formula wlIron (ready) 0.58 (+0.03) 0.28 - 0.55
SIMll..AC®-wlIron (ready) 0.62 (+0.11) 0.29 - 0.58
SIMILAC®-wlIron (ready) 0.60 (±0.04) 0.28 - 0.57
SIMILAC®-Low Iron (powder) 0.66 (±0.05) 0.31 - 0.62
SIMILAC®-wlIron (powder) 0.63 (±0.03) 0.30 - 0.60
SIMILAC®PM60/40-Low Iron (ready) 0.69 (±0.21) 0.30 - 0.60
ISOMIL®-Soy formula wlIron (powder) 0.54 (±0.O2) 0.26 - 0.51
a The average intake in one day in mg.
The average amount of milk consume by infant age 0-1 year old is between
16 - 32 fl.oz.
16 fl. oz. = 16 f).oz. x 29.5 mllfl.oz = 472 ml = 0.472 I
32 fl. oz. = 32 f).oz. x 29.5 mlltl.oz =944 ml = 0.944 I
The intake of mineral in mg/d = 0.472 I x amount of mineral (mg/I).
=0.944 I x amount of mineral (mgll).
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Table Xli. Comparison of theESADDI for Manganese for Age Group 0-1 Year Old
(0.3-1.0 mg/d) and the Estimated Amount Typically Consumed (mg/d) from
Infant Formulas.
Sample Concentration Estimated Intake, mg/d (a)
(±SD), mgfl (16-32oz.ld)
ALIMENTUM®-Protein Hydrolysate 0.25 (±0.01O) 0.12-0.23
wllron (ready)
SlMll...AC®PM60/40-Low iron (ready) 0.05 (±0.005) 0.02-0.05
SIMILAC®Low Iron (ready) 0.08 (±0.008) 0.04-0.08
ISOMIL®-Soy formula wlIron (ready) 0.23 (±O.040) 0.11-0.21
SIMU..AC®-Special Care wllron (ready) 0.17 (±0.032) 0.08-0.16
SlMlLAC®-wlIron (concentrated) 0.07 (±0.005) 0.03-0.06
SlMlLAC®-Low Iron (concentrated) 0.05 (±0.003) 0.03-0.05
SlMILAC®-wlIron (ready) 0.06 (±0.011) 0.03-0.05
ISOMlL®-Soyformula wllron 0.30 (±O.O13) 0.14-0.28
(concentrated)
ISOMlL®-Soy formula w/lron (ready) 0.31 (±O.004) 0.14-0.29
SlMILAC®-wllron (ready) 0.06 (±0.005) 0.03-0.06
SIMILAC®-wllron (ready) 0.06 (±0.006) 0.03-0.06
SIMILAC®-Low Iron (powder) 0.06 (±0.006) 0.03-0.06
SIMlLAC®-wlIron (powder) 0.07 C±0.OO9) 0.03-0.07
SIMILAC®PM60/40-Low Iron (ready) 0.07 (±O.006) 0.03-0.07
ISOMIL®-Soy formula wllron (powder) 0.33 (±0.007) 0.16-0.31
a The average intake in one day in mg.
The average amount of milk consume by infant age 0-1 year old is between
16 - 32 fl.oz.
16 fl. oz. = 16 fl.oz. x 29.5 mUfI.oz =472 ml =0.472 I
32 fl. oz.. = 32 fl.oz. x 29.5 mllfl.oz = 944 m1 = 0.944 1
The intake of mineral in mg/d = 0.472 1x amount of mineral (mg/l).
= 0.944 I x amount of mineral (mgll).
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Table XIV. Comparison of the RDA for Selenium for Age Group 0-1 Year Old
(10-15 J.Lgfd) and the Estimated Amount Typically Consumed (~gld) from
Infant Formulas.
Sample Concentration Estimated Intake, J.lgld (a)
(±SD), llg/l (16-32oz.ld)
ALIMENTUM®-Protein Hydrolysate 35.33 (±3.40) 16.&5 - 33.35
wlIron (ready)
SIMILAC®PM60/40-Low iron (ready) 41.67 (±2.21) 19.&8 - 39.34
SIMILAC®-Low Iron (ready) 50.67 (±3.68) 24.l7 - 47.83
ISOMIL®-Soy formula wllron (ready) 53.83 (±2.12) 25.68 - 50.82
SIMll.AC®-Special Care wllron (ready) 59.00 C±3.92) 28.14 - 55.70
SIMILAC®- wlIron (concentrated) 46.33 (±2.36) 22.10 - 43.74
SIMILAC®-Low Iron (concentrated) 45.83 (±2.40) 21.86 - 43.26
SIM:ILAC®-wlIron (ready) 48.50 (±2.57) 23.13 - 45.78
ISOMIL®-Soy fonnula wllron 63.50 (±2.25) 30.29 - 59.94
(concentrated)
ISOMIL®-Soy fonnula wllron (ready) 63.50 (±2.25) 30.29 - 59.94
S~AC®-wlIron (ready) 55.50 (±3.57) 26.47 - 53.39
SIMILAC®-wlIron (ready) 62.00 (±4.64) 29.57 - 60.57
SIMILAC®-Low Iron (powder) 55.75 (±2.68) 26.59 - 54.47
SIMILAC®-wlIron (powder) 64.00 (+ 1.23) 30.53 - 60.42
SIMILAC®PM60/4Q-Low Iron (ready) 66.00 (±4.64) 31.4& - 62.30
ISOMIL®-Soy formula wlIron (powder) 50.00 (±4.12) 23.&5 - 47.20
a The average intake in one day in Ilg.
The average amount of milk consume by infant age 0-1 year old is between
16 - 32 fl.oz.
16 fl. oz. = 16 fl.oz. x 29.5 mUfl.oz =472 ml =0.472 1
32 fl. oz. =32 fl.oz. x 29.5 ml./fl.oz =944 ml =0.944 I
The intake of mineral in !1g1d = 0.472 1x amount of mineral (Jigll).
=0.944 I x amount of mineral (J.lgll).
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Figure V. The Ratio Between the 1989 RDA for Zinc and the Estimated Amount
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The 1989 RDA for zinc (5mg/d) for age group 0 - I year old.
A letter assigned to each infant formula (see Appendix B).
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The ESADDI for copper (0.4-0.6 mg/d) for age group 0 - I year old
A Letter assigned to each infant formula (see Appendix B).
The intake obtained from a consumption of 32 fl.oz of infant formula in one
day.




Figure VII. The Ratio Between the ESADDI for Manganese and the Estimated Amount
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x The ESADDI for manganese (0.3-1.0 mg/d) for age group 0 - I year old.
A to P A letter assigned to each infant formula (see Appendix B).
Figure VIII. The Ratio Between the 1989 RDA for Selenium and the Estimated Amount
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The RDA (1989) for selenium (I0-15 ~g/d) for age group 0 - I year old.
A letter assigned to each infant formula (see Appendix B).
The intake obtained from a consumption of 32 fl.oz of infant formula in one
day.





SUMMARY, CONCLUSIONS, AND RECOMMENDATION
Summary
Mineral composition of infant fonnula is different compared to those in breast milk.
The increasing trend towards bottle feeding in the last decade increased the concern towards
getting too much or too little of mitnerals especiany those that are not listed in the
composition label such as manganese and selenium.
Six different infant formulas in three different forms (ready-to-used, concentrated,
and powder) produced by Ross Laboratories (Columbus, Ohio) were used in the
experiment. Those were SIMILAC® with iron, SIMll.AC®PM 60/40 low iron,
ALIMENTUM®Protein Hydrolysate with iron, SIMll..AC® low iron, ISOMIL®Soy
formula with iron, and SIMILAC®Special care with Iron.
Four different minerals, zinc, copper, manganese, and selenium were tested using
the atomic absorption spectrophotometer (Perkin-Elmer 5100 GFAAS - Zeman). Since
zinc and copper were measured in mg, the flame side of spectrophotometer was used.
Manganese and selenium were found in a smaller amount and were measured in Ilg. The
furnace side of spectrophotometer was used since it is more sensitive and more accurate in
measuring mineral present in a very low level.
Three cans or bottles were taken from each lot, and four samples were taken out of
one can or bottle to make a total of 160 samples. Each sample went through wet ashing
using hydrogen peroxide and nitric acid for one week. All dry samples then were diluted
with 1.3 mL of distilled water and 200 ilL of concentrated nitric acid. Before analyzing
the mineral content, different dilutions for different minerals were made.
The content of zinc, copper, manganese, and selenium in infant formulas being
tested were all higher compared to those in breast milk, 4.2 - 8.5 times more for
zinc, 2.2 - 6.9 times more for copper, 8.2 - 55.0 times more for manganese, and 1.8 - 3.3
48
times more for selenium.
The intake of each mineral from infant formulas being tested by average infants
with an average consumption of 16 to 32 fl.oz. were also calculated. For zinc, average
infants get 0.47 to 1.93 times of the RDA. For copper, average infants get 0.43 to 2.7
times of the ESADDI. For manganese, average infants get 0.02 to 0.31 times of the
ESADDI. For selenium, average infants get 1.12 to 4.15 times of the RDA.
Recommendation
Since there were not enougn sample available for the experiment, the significant of
the results of the experiment cannot be determined. The result reported above should be
used to guide further study towards any of these trace minerals to see if they are
consistently high in all infant formulas available in the market, and not only in certain lots.
There has not been a lot of study being done in mineral absorption in infant formula
compared to that in breast milk. For that reason alone, an absorption study to see these
differences will contribute more to our understanding about infant formula, to see if it is a
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Appendix A. List of Infant Formulas in the Study.
Formula Name Major Constituent Iron Content Form Container
Soy-based Cow milk·based Low iron Added Iron Ready-to-feed Concentrated Powdered Can Bottle
SIMILAC~ with Iron x x x x
x x x x
x x x x
x x x x
SIMILAC®PM 60/40 Low iron x x x x
x x x x
ALiMENTUM® Protein x x x x
Hydrolysate with Iron
SIMILAC® Low Iron x x x x
x x x x
x x x x
x x x x
ISOMIL® Soy with Iron x x x x
x x X x
x x x x
SIMILAC® Special Care x x x x
with Iron
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Appendix B. Extra Informations about Infant Formula Used in Study.
Number Name Type Quantity Vol Extra Information Lot # Exp. date
1 ALIMENTUM® Protein Hydrolysate 6 Quart cans 32 f1.oz Do not add water 71787RC Nov. 93
(A) formula wi Iron:
ready-ta-feed
2 SIMILAC®PM60/40 Low Iron formula: 48 bottles 4 t1.oz 20 callfl.oz 71291RN03 Dec. 93
(B) ready-to-feed Do not add water
3 SIMILAC® Low Iron formula: 4 6-packs 8 fl.oz Do not add water 65049RD11 Dec. 93
(C) ready-to-feed
4 1S0MIL® Soy formula wi Iron: 24 cans 8 fl.oz Do not add water 75826RROO Apr. 94
(D) ready-to-feed
5 SIMILAC® Special Care wi Iron: 8 6-packs 4 fl.oz Add water only if 7505RDOI Apr. 94
(E) ready-to-feed directed by physc.
6 SIMILAC® (F) With Iron: concentrated 24 cans 13 fl.oz Add water 73678RAOI May 94
7 SIMU,AC® Low Iron formula: 24 cans 13 fl.oz Add water 73691REOO May 94
(G) concentrated
8 SIMILAC® Low Iron formula: 6 Quart cans 32 fl.oz Do not add water 73704REOO Aug. 94
(H) ready-to-feed
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Appendix B. Extra Infonnations about Infant Fonnula Used in the Study (continue).
Number Name Type Quantity Vol Extra Information Lot # Exp. date
9 ISOMIL® Soy formula wi Iron: 24 cans 13 £1.oz Add water 73664REOO Aug. 94
(I) concentrated Milk/Lactose free
10 ISOMIL® Soy fonnula wi Iron: 6 Quart cans 32 £1.oz Do not add water 74665RC Sept. 94
(1) ready-to-feed
11 SIMILAC® (K) With Iron: ready-to-feed 6 Quart cans 32 £1.oz Do not add water 74772REOO Sept. 94
12 SIMILAC® (L) With Iron: ready-to-feed 4 6-packs 8 fl.oz Do not add water 75087RDOI Oct. 94
13 SIMILAC® (M) Low Iron fonnula : 6 cans I lb. Add water 71573RBOO Dec. 94
powder
14 SIMILAC® (N) With Iron: powder 6 cans lIb. Add water 74805RBOO Mar. 95
15 SIMILAC®PM60/40 Low Iron fonnula : 6 cans 1 lb. Add water 76266RBOI May 95
(0) powder
16 ISOMIL® Soy formula wi Iron: 6 cans 14 oz. Add water 7621ORBOO May 95
(P) powder MilklLactose free
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Appendix C. Tubes Configuration in Heating Block.
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Appendix D. Dry Weight and pH of Samples After Wet Ashing.
Tube # Sample Tube wt. Tube+Dry Sample wt. Dry Sample wt. pH
g. g. g.
] Al 5.31379 5.32243 0.00864 6.86
2 5.22038 5.22907 0.00869
3 5.33630 5.34518 0.00888
4 5.40381 5.41353 0.00972
5 A2 5.32799 5.33650 0.00851 6.88
6 5.40953 5.41740 0.00787
7 5.26929 5.27736 0.00807
8 5.28210 5.29077 0.00867
9 A3 5.29491 5.30525 0.01034 6.88
10 5.32711 5.33490 0.00779
11 5.32778 5.33678 0.00090
12 5.26381 5.27231 0.00850
13 Bl 5.31016 5.31534 0.00518 6.92
14 5.35320 5.35843 0.00523
15 5.33268 5.33895 0.00627
16 5.36602 5.37161 0.00559
17 B2 5.28993 5.29548 0.00555 7.00
18 5.32433 5.33145 0.00712
19 5.34467 5.35153 0.00686
20 5.27524 5.28022 0.00498
21 B3 5.26252 5.26814 0.00562 6.93
22 5.28706 5.29215 0.00509
23 5.24714 5.25334 0.00620
24 5.34670 5.35139 0.00469
25 Cl 5.39852 5.40575 0.00723 6.61
26 5.27308 .5.28166 0.00858
27 5.23609 5.24401 0.00792
28 5.41907 5.42578 0.00671
29 C2 5.35927 5.36715 0.00788 6.61
30 5.29572 5.30280 0.00708
31 5.34429 5.35071 0.00642
32 5.30950 5.31482 0.00532
33 C3 5.19662 5.20248 0.00586 6.63
34 5.31583 5.32129 0.00546
35 5.31901 5.32414 0.00513
36 5.37587 5.38072 0.00485
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Appendix D. Dry Weight and pH of Samples After Wet Ashing (continue).
Tube # Sample Tube wt. Tube+Dry Sample wt. Dry Sample wt. pH
g. g. g.
37 Dl 5.36814 5.37459 0.00645 6.78
38 5.23711 5.24407 0.00696
39 5.36128 5.36773 0.00645
40 5.27698 5.28390 0.00692
41 D2 5.24777 5.25575 0.00798 6.80
42 5.23021 5.23789 0.00768
43 5.31377 5.32094 0.00717
44 5.35660 5.36312 0.00652
45 D3 5.27788 5.28612 0.00824 6.81
46 5.31878 5.32835 0.00957
47 5.26316 5.27144 0.00828
48 5.30187 5.31070 0.00883
49 El 5.27751 5.29099 0.01348 6.71
50 5.22297 5.23694 0.01397
51 5.21985 5.23376 0.01391
52 5.28304 5.29744 0.01440
53 E2 5.38495 5.39791 0.01296 6.73
54 5.35388 5.36767 0.01379
55 5.35161 5.36590 0.01429
56 5.28503 5.29917 0.01414
57 E3 5.27836 5.29147 0.01311 6.73
58 5.26202 5.27524 0.01322
59 5.24704 5.26090 0.01386
60 5.32760 5.34094 0.01334
61 F1 5.27556 5.28236 0.00680 6.73
62 5.30028 5.30697 0.00669
63 5.25729 5.26575 0.00846
64 5.26196 5.26889 0.00694
65 F2 5.29913 5.30493 0.00580 6.70
66 5.26356 5.26972 0.00616
67 5.19173 5.19911 0.00738
68 5.29454 5.30170 0.00716
69 F3 5.24424 5.25128 0.00704 6.70
70 5.26724 5.27448 0.00724
71 5.35439 5.36227 0.00788
72 5.26631 5.27332 0.00701
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Appendix D. Dry Weight and pH of Samples After Wet Ashing (continue).
Tube # Sample Tube wt. Tube+Dry Sample wt. Dry Sample wt. pH
g. g. g.
73 Gl 5.27125 5.27881 0.00756 6.68
74 5.29236 5.30025 0.00789
75 5.23209 5.23930 0.00721
76 5.22818 5.23588 0.00770
77 G2 5.15495 5.1635 0.00855 6.68
78 5.25484 5.26185 0.00701
79 5.38393 5.39089 0.00696
80 5.36974 5.37742 0.00768
81 G3 5.20513 5.21253 0.00740 6.70
82 5.30212 5.30872 0.00660
83 5.32377 5.33102 0.00725
84 5.27969 5.28709 0.00740
85 HI 5.29869 5.30616 0.00757 6.73
86 5.22835 5.23576 0.00741
87 5.29236 5.30042 0.00806
88 5.35749 5.36529 0.00780
89 H2 5.40292 5.41405 0.01113 6.73
90 5.24941 5.25818 0.00877
91 5.17700 5.18626 0.00926
92 5.30529 5.31216 0.00678
93 H3 5.21725 5.22317 0.00592 6.75
94 5.31242 5.31862 0.00620
95 5.27883 5.28679 0.00796
96 5.24170 5.24784 0.00614
97 II 5.23680 5.24401 0.00721 6.70
98 5.28907 5.29736 0.00829
99 5.35280 5.36046 0.00766
1O0 5.37713 5.38471 0.00758
101 12 5.26470 5.27212 0.00742 6.70
102 5.22515 5.23273 0.00758
103 5.28948 5.29668 0.00720
104 5.25378 5.26080 0.00702
105 J1 5.33783 5.34590 0.00807 6.58
106 5.23594 5.24608 0.01014
107 5.24154 5.25180 0.01026
109 5.21084 5.21885 0.00801
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Appendix D. Dry Weight and pH of Samples After Wet Ashing (continue).
Tube # Sample Tube wt. Tube+Dry Sample wt. Dry Sample wt. pH
g. g. g.
110 J2 5.31294 5.32091 0.00797 6.58
111 5.31242 5.32113 0.00871
112 5.27121 5.28032 0.00911
113 5.26800 5.27394 0.00594
114 Kl 5.23951 5.24545 0.00594 6.55
115 5.28482 5.29263 0.00781
116 5.35282 5.36016 0..00734
117 5.23736 5.24338 0.00602
118 K2 5.37774 5.38479 0.00705 6.53
119 5.26811 5.27608 0.00797
120 5.18499 5.19102 0.00603
121 5.19141 5.19785 0.00644
122 Ll 5.34438 5.35384 0.00946 6.56
123 5.29994 5.30869 0.00875
124 5.34788 5.35447 0.00659
125 5.34695 5.35324 0.00629
126 L2 5.33971 5.34851 0.00880 6.50
127 5.28465 5.29047 0.00582
128 5.33094 5.33761 0.00667
129 5.37604 5.38495 0.00891
130 MI 5.25632 5.28022 0.02390 6.80
131 5.22217 5.23175 0.00958
132 5.27047 5.28176 0.01129
133 5.28047 5.29261 0.01214
134 M2 5.28809 5.30156 0.01135 6.76
135 5.27886 5.28670 0.00784
136 5.31650 5.32438 0.00788
137 5.28745 5.29807 0.01062
138 N1 5.30793 5.31635 0.00842 6.85
139 5.3374 5.34538 0.00764
140 5.32882 5.33636 0.00754
141 5.33576 5.35366 0.00790
142 N2 5.25948 5.26596 0.00648 6.83
143 5.29457 5.30029 0.00572
144 5.29035 5.29736 0.00701
145 5.28880 5.29558 0.00678
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Appendix D. Dry We~ght and pH of Samples After Wet Ashing (continue).
Tube # Sample Tube wt. Tube+Dry Sample wt. Dry Sample wt. pH
g. g. g.
146 01 5.38141 5.38656 0.00515 6.97
147 5.31889 5.32322 0.00433
148 5.34713 5.35129 0.00416
149 5.30876 5.31451 0.00575
150 02 5.18965 5.19332 0.00367 6.93
151 5.22572 5.23169 0.00597
152 5.23820 5.24433 0.00613
153 5.26303 5.26853 0.00550
154 PI 5.25227 5.26198 0.00971 6.75
155 5.22399 5.23363 0.00964
156 5.24804 5.26006 0.01202
157 5.32180 5.33179 0.00999
158 P2 5.27348 5.28592 0.01244 6.75
159 5.28407 5.29654 0.01247
160 5.23301 5.24425 0.01124
161 5.32948 5.33928 0.00980
163 Bl * 5.32265 5.32270 0.00005
164 B2 5.26848 5.26872 0.00024
165 B3 5.28642 5.28650 0.00008
166 B4 5.29931 5.29947 0.00016
167 B5 5.21351 5.21364 0.00013
168 B6 5.23869 5.23975 0.00106
169 B7 5.31960 5.32079 0.00119
170 B8 5.29576 5.29713 0.00137
171 B9 5.33977 5.33988 0.00011
172 BI0 5.27144 5.27153 0.00009
173 Bll 5.26695 5.36703 0.00008
174 B12 5.27302 5.27328 0.00026
175 B13 5.16465 5.16477 0.00012
176 B14 5.22019 5.22031 0.00012
177 B15 5.24061 5.24094 0.00033
Tube 108 and 162 were broke and thrown away.
* Are all the blank tubes.
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Appendix E. Atomic Absorption Result Data.
Sample Tube # Zn in mgll eu in mgll Mn in Ilg!l Se in ~gIl (a)
Al 1 5.16 0.50 (b) 36
2 5.21 0.61 241 38
3 5.10 0.61 239
4 4.84 0.64 246
A2 5 5.15 0.64 236 36
6 5.36 0.66 246
7 5.57 0.64 250
8 5.48 0.65 240 30
A3 9 3.79 0.60 236
10 5.28 0.64 235 32
11 5.02 0.68 268
12 5.44 0.65 258 40
B1 13 5.08 0.60 48 43
14 5.76 0.63 47 39
15 (c) (c) (c)
16 5.60 0.61 57
B2 17 5.29 0.66 56
18 5.98 0.61 48 41
19 5.85 0.64 55 39
20 5.86 0.63 55
B3 21 5.91 0.63 54
22 5.15 0.66 (b) 43
23 5.61 0.58 43
24 5.81 0.57 55 45
Cl 25 4.80 0.59 78 57
26 4.52 0.56 88
27 5.86 0.64 89 51
28 5.23 0.65 93
C2 29 5.27 0.60 81 48
30 5.59 0.58 80 45
31 5.62 0.61 (b)
32 4.. 39 0.59 (b)
C3 33 5.39 0.62 96
34 5.81 0.57 80 52
35 5.53 0.61 90 51
36 5.21 0.60 92
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Appendix E. Atomic Absorption Result Data (continue).
Sample Tube# Zn in mgll Cu in mgll Mn in J.Lgfl Se inllg!l (a)
D1 37 5.24 0.57 278 50
38 5.21 0.58 271
39 4.89 0.59 223 53
40 5.53 0.62 213
D2 41 5.17 0.60 300 55
42 5.50 0.64 245 57
43 5.28 0.62 282
44 5.76 0.62 236
D3 45 5.40 0.58 201 54
46 (d)
47 4.50 0.29 265 54
48 5.32 0.60 196
E1 49 10.54 1.74 211
50 10.80 1.81 214 57
51 10.07 1.80 203 53
52 10.85 1.55 149
E2 53 10.73 1.69 136
54 10.12 1.80 179
55 10.96 1.84 154 58
56 9.25 1.81 177 58
E3 57 8.66 1.38 124 64
58 10.69 1.76 144 64
59 10.21 1.64 140
60 9.52 1.83 209
F1 61 5.17 0.38 (b) 46
62 5.43 0.65 60 44
63 5.46 0.74 70
64 5.43 0.20 68
F2 65 5.38 0.58 70
66 5.38 0.65 74
67 4.76 0.76 56 45
68 5.19 0.70 61 49
F3 69 5.06 0.49 66 50
70 5.23 0.68 67
71 (b) (b) 61
72 (b) (b) 70 44
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Appendix E. Atomic Absorption Result Data (continue).
Sample Tube# Zn in mgll Cu in rngll Mn in ~gIl Se in ~gIl (a)
G1 73 2.17 0.62 58
74 5.47 0.70 52 46
75 5.19 0.65 54
76 5.43 0.64 51 42
G2 77 4.98 0.80 51
78 5.47 0.61 57 47
79 5.81 0.62 54 49
80 5.67 0.66 51
G3 81 5.30 0.41 50 45
82 5.16 0.61 48
83 5.38 0.62 53
84 5.53 0.62 48 46
HI 85 3.78 0.56 69 45
86 5.12 0.66 45 50
87 5.27 0.54 (b)
88 5.24 0.63 (b)
H2 89 5.40 0.62 53
90 5.10 0.56 47 51
91 5.44 0.61 54 51
92 5.10 0.63 80
H3 93 4.88 0.61 61
94 5.03 0.63 50 49
95 5.36 0.64 50
96 5.23 0.62 46 45
11 97 5.19 0.57 266
98 5.29 0.61 301
99 5.45 0.59 298 66
100 5.36 0.58 304 65
12 101 5.07 0.63 (b) 63
102 5.38 0.34 305 60
103 5.55 0.57 (b)
104 4.50 0.59 296
11 105 5.33 0.54 301
106 5.50 0.61 304 67
107 5.85 0.59 307 62
109 5.24 0.59 299
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Appendix E. Atomic AbsOIption Result Data (continue).
Sample Tube# Zn in mgll eu in mgll Mn in Ilg!l Se in Ilg!l (a)
12 110 4.80 0.56 303
111 5.75 0.63 307 63
112 5.60 0.64 305 62
113 5.55 0.60 313
Kl 114 5.56 0.66 74
115 3.84 0.66 64 51
116 5.46 0.66 61 59
117 5.66 0.34 53
K2 118 4.42 0.61 56
119 5.64 0.70 66
120 5.69 0.63 61 59
121 5.84 0.66 66 53
Ll 122 5.38 0.56 61
123 5.32 0.66 68
124 5.39 0.64 63 63
125 5.36 0.62 49 55
L2 126 4.80 0.56 56 68
127 5.38 0.56 67
128 5.39 0.60 68
129 5.38 0.61 58 62
Ml 130 5.13 0.65 (b)
131 5.02 0.63 (b)
132 5.32 0.68 81 54
133 5.19 0.66 68 53
M2 134 5.20 0.72 46
135 5.30 0.61 55 56
136 5.18 0.59 58 60
137 5.13 0.70 55
Nl 138 5.48 0.61 89
139 5.56 0.59 69
140 5.51 0.67 65 64
141 5.13 0.70 55 62
N2 142 5.02 0.62 62 65
143 5.27 0.66 59
144 5.08 0.62 62
145 3.76 0.63 59 65
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Appendix E. Atomic Absorption Result Data (continue).
Sample Tube# Zn in mgll eu in rngll Mn in IJ.gI1 Se in llg!l (a)
01 146 5.17 0.60 71 62
147 5.66 0.76 76
148 5.69 0.22 71
149 5.58 0.82 69 61
02 150 4.98 0.66 62
151 4.82 0.67 63 72
152 4.98 0.65 62 69
153 4.95 0.73 78
PI 154 5.34 0.54 326 57
155 4.62 0.54 337 47
156 4.64 0.54 343
157 5.39 0.58 324
P2 158 5.24 0.54 327 47
159 4.90 0.53 321 49
160 5.09 0.53 334
161 5..21 0.53 327
a. For selenium, 2 out of 4 samples with the closest weight were chosen from each
can for mineral analysis.
b. Missing samples.
c. The particular sample was randomly selected for preleminary testing to test the
equipment.





Candidate for the Degree of
Master of Science
Thesis: SELENIUM, MANGANESE, ZINC AND COPPER CONTENT
IN INFANT FORMULA
Major Field: Nutritional Sciences
Biographical:
Personal Data: Born in Bandung, Indonesia, on July 28, 1970, the daughter
of David Beny Achmadi and Maria Eva Mansoor.
Education: Graduated from St. Ursula High School, Jakarta, Indonesia in
May 1989; received Bachelor of Science degree in Nutritional
Sciences from Oklahoma State University, Stillwater, Oklahoma in
May 1993. Completed the requirements for the master of Sci.ence
degree with a major in Nutritional Sciences at Oklahoma State
University in December 1995.
Experiences: Employed by Oklahoma State University as a graduate research
assistant in the Department of Nutritional Sciences, May 1993 to
July 1995. Employed by Oklahoma State University as a graduate
research assistant in the Department of Animal Science, September
1995 to November 1995.
